BioProduction 2014

Optimise, streamline and reduce timelines whilst ensuring product quality and regulatory success.


BioProduction 2014 8-9 Oct 2014 Barceló Sants, Barcelona, Spain
Submit new post
Thank you for posting.
Share it:

Please join us in Barcelona this October for BioProduction 2014; Europe’s leading and largest event for a comprehensive update on operational strategies, technologies, regulatory challenges, manufacturing production and process development in biological manufacturing.

TRACK 1 Upstream Processing, Raw Material Control & Alternative Expression Systems
TRACK 2 Continuous Manufacturing
TRACK 3 Recovery and Purification
TRACK 4 Analytical Support, & Formulation
TRACK 5 QbD and Process Validation
TRACK 6 Development & Manufacturing of Novel Molecules
TRACK 7 Manufacturing Strategies: Improving Productivity & Profitability
TRACK 8 Single- Use Implementation
TRACK 9 Flexible Facilities & Manufacturing of the Future

60+ Big Name Case Studies
9 Focused Tracks over 2-Days
40+ Hours of New Science
6 Interactive Workshops led by Industry Experts
11 + Hours Networking Opportunities – Online Networking, Networking Breaks and Drinks Reception + High Speed Partnering!

The 2014 programme highlights include:

Streamlining to Create an Efficient Scale-Up & Technology Transfer Process
Alternative Expression Systems
Raw Material Control
Challenges & Opportunities of Continuous Manufacturing
Latest Innovations for Protein Purification
Dealing with Unexpected PTM’s
Stable High Concentration Formulation
Detecting & Eliminating Aggregation
Manufacturing Production for Novel Biopharmaceuticals
Biosimilars and Biobetters
Achieving and Maintaining Manufacturing Excellence
Flexible Facility Design
Using Single-Use Technology to Improve Upstream Processing



Conference Only Including Networking Dinner: GBP 1699

Speakers: Duncan Low (Amgen), Professor Massimo Morbidelli (ETH Zurich), Professor David Wood (Ohio State University), Prof Manuel Carrondo (IBET), Dr Alistair Kippen (MedImmune), Dr Laenen Lada (Genzyme), Dr Wolfgang Noe (Agensys), Dr Thorsten Peuker (Sartorius Stedim Biotech GmbH), Professor J. Christopher Love (MIT), Dr Hitto Kaufman (Boehringer Ingelheim), Dr Sofie Goetschalckx (Genzyme), Dr Otmane Boussif (Sanofi Pasteur), Dr Heidi J. Hoffmann (Sutro Biopharma), Dr Regis Sodoyer, ( Technological Research Institute Bioaster), Professor Christoph Herwig (Vienna University of Technology), Dr Benoit Mothes (Sanofi), Dr Roger-Marc Nicoud (Novasep), Professor Rainer Hahn (University of Natural Resources and Life Sciences Vienna), Dr Darya Burakov (Regeneron Pharmaceuticals, Inc.), Dr Romas Skudas (Merck Millipore – Process Solutions), Dr Carsten Voß (Bio-Rad Laboratories GmbH), Professor Tudor Arvinte (Therapeomic Inc), Professor Roy Jefferis (University of Birmingham), Dr Mattia Matasci (Philochem AG), Liz Dooley (Janssen Supply Chain), Dr Daryl Fernandes (Ludger Ltd), Berthold Boedeker (Bayer Pharma AG), Kenneth Green (Pfizer)